Survodutide
BI 456906
Survodutide is a dual glucagon/GLP-1 receptor agonist marketed for weight loss, blood sugar control, and liver fat reduction in MASH.
Peptide Explorer
Browse 121 peptide profiles with research summaries, known risks, interactions, regulatory information, and cited studies.
121 peptide profiles12 categories
121 peptides
BI 456906
Survodutide is a dual glucagon/GLP-1 receptor agonist marketed for weight loss, blood sugar control, and liver fat reduction in MASH.
Liver Bioregulator
Svetinorm is a liver-derived bioregulator peptide marketed to aid liver regeneration in hepatitis, chemo recovery, and general liver strain.
Dipeptide Diaminobutyroyl Benzylamide Diacetate
A synthetic tripeptide mimicking waglerin-1 from Temple Viper venom, used topically to relax facial muscles and soften expression lines as a Botox alternative.
Palmitoyl Tripeptide-5
A synthetic peptide applied to skin, marketed for firmness and fine-line reduction by signaling skin cells into collagen-production mode.
Thymosin Beta-4 Fragment
A synthetic fragment of thymosin beta-4, marketed for tendon, muscle, and ligament recovery.
Egrifta
A stabilized GHRH analog, FDA-approved to reduce visceral fat in HIV lipodystrophy, used off-label for fat loss, lipid gains, and GH restoration.
A synthetic four-amino-acid peptide marketed as a bioregulator for testosterone normalization and male reproductive support.
Thymogen · EW Dipeptide
A dipeptide (Glu-Trp) marketed for immune restoration and healthy aging by acting on T lymphocytes and thymic tissue.
Thymaline
A thymic peptide extract marketed to restore immune function and normalize T-cell balance in aging adults.
Zadaxin
A synthetic 28-amino-acid peptide marketed as an immune modulator for immune support, viral infections, and cancer.
TB4 · Tβ4
A 43-amino-acid peptide, sold mostly as the synthetic fragment TB-500 and marketed for wound healing and tendon and muscle repair.
Thyroid Bioregulator
A thyroid-tissue-derived bioregulator peptide, marketed to support and normalize thyroid function in aging adults.
Mounjaro · Zepbound
A dual GIP/GLP-1 receptor agonist used for weight loss and metabolic health.
Thyrotropin-Releasing Hormone · Protirelin
A tripeptide that triggers pituitary release of TSH and prolactin, used off-label for effects on mood, alertness, and seizure threshold.
Collagen Fragment · Gly-Pro-Hyp
A tripeptide mimicking collagen's Gly-Pro-Hyp motif, marketed to boost skin collagen via fibroblast signaling.
Trelstar · Decapeptyl
A synthetic GnRH agonist that suppresses testosterone or estrogen to castrate levels after an initial hormone surge.
Vascular Bioregulator
A bioregulator peptide complex derived from blood vessel tissue, marketed to support vascular wall integrity and elasticity as vessels age.
A dipeptide bioregulator (Glu-Asp) marketed for bladder and prostate health, meant to normalize detrusor muscle function and reduce urinary tract inflammation.
A tripeptide bioregulator (lysine-glutamate-aspartate) marketed for vascular and endothelial health and slower biological aging.
Pentapeptide-3V
A synthetic pentapeptide marketed as a topical alternative to botulinum toxin, blocking acetylcholine at the neuromuscular junction to soften expression lines.
Vilon is a synthetic dipeptide (Lys-Glu) marketed to support immune recovery and thymic function in aging.
Vasoactive Intestinal Peptide
A naturally occurring peptide marketed for anti-inflammatory, lung, and gut effects.
Viking 2735
VK2735 is a dual GLP-1/GIP receptor agonist for rapid weight loss, marketed as an alternative to GLP-1-only drugs.
Showing 97-121 of 121
How to read a peptide profile. Overview brings together the bottom line, classification, studied uses, evidence limits, cautions, and risks. Full record includes detailed interactions and research, prescribing labels for approved drugs, monitoring and lab notes, regulatory details, cited studies, and FAQs.
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.